Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • On the Market
  • Published:

Complement inhibitory therapeutics and xenotransplantation

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Sandrin, M.S., Vaughan, H.A., Dabkowski, P.L. & McKenzie, I.F.C., IgM antibodies in human serum react predominantly with gal(α1–3)gal epitopes. Proc. natn. Acad. Sci. U.S.A. 90, 11391–11395 (1993).

    Article  CAS  Google Scholar 

  2. Bach, F.H., Turman, M.A., Vercellotti, G.M., Platt, J.L. & Dalmasso, A.P. Accommodation: A working paradigm for progressing toward discordant xenografting. Transplantn Proc. 23, 205–208 (1991).

    CAS  Google Scholar 

  3. Baldwin, W.M., Pruitt, S.K., Brauer, R.B., Daha, M.R. & Sanfilippo, F. Complement in organ transplantation. Transplantation 59, 797–808 (1995).

    Article  Google Scholar 

  4. Ryan, U.S. Complement inhibition: The sine qua non of xenotransplantation?. Xeno 2, 19–22 (1994).

    Google Scholar 

  5. Thomas, L.J. & Ryan, U.S. Immunological consequences of organ transplantation: Implications for therapeutic development. J. Heart Lung Transplantn (in the press).

  6. Dalmasso, A.P., Vercellotti, G.M., Platt, J.L. & Bach, F.H. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor: Potential for prevention of xenograft hyperacute rejection. Transplantation 32, 530–533 (1991).

    Article  Google Scholar 

  7. McCurry, K.R. et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med. 1, 423–427 (1995).

    Article  CAS  Google Scholar 

  8. Cozzi, E. & White, D.J.G. The generation of transgenic pigs as potential organ donors for man. Nature Med. 1, 964–966 (1995).

    Article  CAS  Google Scholar 

  9. Foder, W.L. & Squinto, S.P. Engineering of transgenic pigs for xenogeneic organ transplantation. Xeno 3, 23–25 (1995).

    Google Scholar 

  10. Weisman, H.F. et al. Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249, 146–151 (1990).

    Article  CAS  Google Scholar 

  11. Pruitt, S.K. et al. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. Transplantation 52, 868–873 (1992).

    Article  Google Scholar 

  12. Xia, W. et al. Prolongation of guinea pig cardiac xenograft survival in rats by soluble human complement receptor type 1. Transplantn Proc. 24, 479–480 (1992).

    CAS  Google Scholar 

  13. Xia, W., Fearon, D.T. & Kirkman, R.L. Effect on repetitive doses of soluble human complement receptor type 1 on survival of discordant cardiac xenografts. Transplantn Proc. 25, 410–411 (1993).

    CAS  Google Scholar 

  14. Pruitt, S.K. et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57, 363–370 (1994).

    Article  CAS  Google Scholar 

  15. Candinas, D. et al. Soluble complement receptor type 1 and cobra venom factor in discordant xenotransplantation. Transplantn Proc. (in the press).

  16. Pruitt, S.K. et al. Continuous complement (C) inhibition using soluble complement receptor type 1 (sCRI): Effect on hyperacute rejection (HAR) of pig-to-primate cardiac xenografts (Xgs). Transplantn Proc. (in the press).

  17. Bannett, A.D., McAlack, R.F., Raja, R., Baquero, A. & Morris, M. Experiences with known ABO-mismatched renal transplants. Transplantn Proc. XIX, 4543–4546 (1987).

    Google Scholar 

  18. Alexandre, G.P.J. et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplantn Proc. XIX, 4538–4542 (1987).

    Google Scholar 

  19. Ryan, U.S., ed. Endothelial Cells I–III (CRCBoca Raton, Florida, 1988).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ryan, U. Complement inhibitory therapeutics and xenotransplantation. Nat Med 1, 967–968 (1995). https://doi.org/10.1038/nm0995-967

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0995-967

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing